Dexcom is in talks to acquire device firm Insulet

The US-based company behind glucose-monitoring systems could become a giant on the diabetes device market following a rumored acquisition of Insulet, a maker of insulin pumps.
Photo: Jens Kalaene/AP/Ritzau Scanpix
Photo: Jens Kalaene/AP/Ritzau Scanpix
By Ed Hammond and Michelle F. Davis, bloomberg

Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in diabetes devices, according to people with knowledge of the matter. Insulet rose as much as 16% in after-market trading on the news.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading